Arizona State Retirement System’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Arizona State Retirement System’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,068	Closed	-$908K	–	2258
2022 Q2	$908K	Buy	12,068 +699	+6%	+$31.1K	0.01%	1014
2022 Q1	$305K	Buy	11,369 +66	+0.6%	+$2.22K	﹤0.01%	1793
2021 Q4	$539K	Sell	11,303 -78	-0.7%	-$3.49K	﹤0.01%	1488
2021 Q3	$756K	Buy	11,381 +251	+2%	+$17.9K	0.01%	1274
2021 Q2	$868K	Sell	11,130 -790	-7%	-$58.4K	0.01%	1203
2021 Q1	$1.13M	Buy	11,920 +392	+3%	+$46.6K	0.01%	1035
2020 Q4	$1.41M	Buy	11,528 +1,353	+13%	+$148K	0.01%	851
2020 Q3	$889K	Buy	10,175 +2,724	+37%	+$190K	0.01%	977
2020 Q2	$481K	Buy	+7,451	New	+$430K	0.01%	1145

Arizona State Retirement System's TPTX Position: Q3 2022 in Review

Arizona State Retirement System sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 12,068 shares — an estimated $908K sold.

Arizona State Retirement System first reported a position in TPTX in Q2 2020 and held it in 9 quarters. The position peaked at $1.41M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Arizona State Retirement System reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Arizona State Retirement System sold 12,068 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $908K.
Arizona State Retirement System first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
Arizona State Retirement System's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.41M in Q4 2020.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Arizona State Retirement System's 13F filing for Q3 2022, filed 7 Nov 2022.